Coronary heart assault prediction startup Cleerly scores $192M and extra digital well being fundings

Heart problems-focused Cleerly scored $192 million in Sequence C financing, a bit greater than a yr after the corporate launched with a $43 million Series B. 

The newest spherical, led by T. Rowe Worth and Constancy Administration and Analysis Firm, brings Cleerly’s complete elevate to $248 million. 

Different contributors within the spherical embrace Sands Capital, Piper Sandler’s Service provider Banking and Heartland Healthcare Capital funds, Mirae Asset Capital, Peter Thiel, Breyer Capital, Novartis, Vensana Capital, LRVHealth, New Leaf Ventures, Cigna Ventures and DigiTx Companions.

The corporate affords an AI-backed device that evaluates CT angiograms for plaque build-up on the guts arteries’ partitions, which Cleerly pitches as a solution to catch coronary heart illness early. It should use the Sequence C capital to develop its workforce and industrial capabilities in addition to put money into analysis. 

“At Cleerly, we’re enthusiastic about our mission to create a brand new customary of take care of coronary heart illness,” CEO and founder Dr. James Min mentioned in an announcement. “We’re grateful for this spherical of financing that can additional allow our work and imagine it supplies a convincing vote of confidence in our imaginative and prescient for the way forward for cardiovascular care.

“The established order for coronary heart well being merely isn’t adequate – for sufferers, suppliers, or payors – and our confirmed method to inspecting for early indicators of coronary heart illness by means of the build-up of arterial plaque guarantees to ship the change we want proper now.”

Elation Well being, which affords instruments for telehealth, affected person engagement, and an EHR geared towards main care suppliers, raised $50 million in Sequence D funding. 

The spherical was led by Era Funding Administration and Ascension Ventures, with participation from Threshold Ventures, Ascend Companions, and particular person traders, together with Firefly Well being CEO Fay Rotenberg, and former athenahealth CEO and founder Jonathan Bush.

Elation most just lately scored $40 million in Sequence C financing in 2020. The newest elevate brings its complete funding pot to $108.5 million.

Affected person consumption chatbot Well being Word closed a $17 million Sequence A funding spherical led by SignalFire. 

Different traders within the spherical embrace UnityPoint Well being, Northwell Holdings and Cedars Sinai Well being Ventures.

The startup affords a platform that may message sufferers to verify their appointments, focus on well being historical past and issues, after which enter that info into the EHR earlier than their go to. Well being Word will use the funding to hurry market growth, add EHR integrations, and put money into analysis and improvement so as to add to their instruments. 

“The imaginative and prescient for Well being Word has all the time been to help care suppliers by empowering sufferers to create and work together with their well being knowledge earlier than the go to begins, thus decreasing the rising documentation burden that frustrates the overwhelming majority of docs and care groups,” CEO and cofounder Dr. Joshua Reischer mentioned in an announcement.

“The extra funding will assist Well being Word replicate its early success with mid-size practices and well being methods at scale, which is sorely wanted as our well being system continues to function with restricted workers.”

Summer time Well being raised $7.5 million in seed funding for its messaging service that enables mother and father to talk with pediatricians about their kid’s well being and improvement. The service is now accessible in public beta testing.

The spherical was led by Alfred Lin at Sequoia Capital and Deena Shakir at Lux Capital, with participation from Field Group, Metrodora Ventures, Shrug Capital, Springbank Collective, Coalition Operators, Transferring Ventures, Maven founder and CEO Kate Ryder, Hims & Hers founder and CEO Andrew Dudum, Mos founder and CEO Amira Yahyaoui, and digital well being investor Alyssa Jaffee.

RxLive, which affords instruments for telepharmacy and drugs administration, scooped up $5 million in a Sequence A funding spherical, led by SpringTide, with participation from Cardinal Well being.

The startup plans to make use of the funds to rent for its engineering, analytics, and gross sales and advertising groups, and to enhance its medicine administration platform. 

“With the transfer to value-based care, the in a single day adoption of telemedicine, and rising significance and emphasis on managing pharmacy spend, RxLive is placing scientific pharmacists again the place they belong,” RxLive cofounder and chief pharmacy officer Kristen Engelen mentioned in an announcement.

 “We give sufferers the one-on-one medicine experience and a focus they should enhance high quality of life, and the know-how and companies healthcare organizations want to enhance outcomes.”